INVESTIGATION ALERT: Berger Montague PC Investigates Baxter International Inc.'S Board Of Directors For Breach Of Fiduciary Duties (NYSE: BAX)
Shareholders of Baxter may learn more about this investigation by contacting Berger Montague: Radha Raghavan at rraghavan@ bergermontague or (332) 271-8908, or Andrew Abramowitz at ... or (215) 875-3015, or CLICK HERE.
Berger Montague's investigation is focused on whether Baxter's Board of Directors breached its fiduciary duties in the manner in which it oversaw the Company's marketing and sale of the Novum LVP, a pump used for the controlled delivery of intravenous fluids, such as blood, medication, and nutrients. In July 2025, Baxter announced that it would“voluntarily and temporarily pause shipments and planned installations of the Novum LVP.”
About Berger Montague
Berger Montague is one of the nation's preeminent law firms focusing on complex civil litigation, class actions, and mass torts in federal and state courts throughout the United States. With more than $2.4 billion in 2025 post-trial judgments alone, the Firm is a leader in the fields of complex litigation, antitrust, consumer protection, defective products, environmental law, employment law, securities, and whistleblower cases, among many other practice areas. For over 55 years, Berger Montague has played leading roles in precedent-setting cases and has recovered over $50 billion for its clients and the classes they have represented. Berger Montague is headquartered in Philadelphia and has offices in Chicago; Malvern, PA; Minneapolis; San Diego; San Francisco; Toronto, Canada; Washington, D.C., and Wilmington, DE.
Contacts:
Radha Raghavan, Associate
Berger Montague
(332) 271-8908
rraghavan@
Andrew Abramowitz, Senior Counsel
Berger Montague
(215) 875-3015
...
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment